Abstract
The serum IgE response to the synthetic polypeptide antigen L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) was investigated. The present study details the experimental conditions required to elicit optimal IgE anti-GAT antibody titers, the genetics controlling this response, and the ability of anti-suppressor cell treatments to affect the magnitude and duration of IgE anti-GAT levels in responder and nonresponder strains of mice. Significant IgE anti-GAT titers were obtained in BALB/c (IgG responder) mice after administration of 1 to 100 µg of GAT in adjuvant (Maalox or Maalox-pertussis), with optimal secondary IgE titers after challenge with 1 or 10 µg doses. All IgE responses were transient in comparison to IgG antibody levels. IgE anti-GAT immunity was found to be regulated by a gene(s) in the I-A/I-B subregion of the H-2 complex, in agreement with earlier studies on serum IgG or cell-mediated immunity. Mice bearing the H-2ja, p, q, s haplotypes were nonresponders, and treatment of SJL (H-2s) or DBA/1 (H-2q) mice with cyclophosphamide or low dose irradiation to remove suppressor cells failed to permit IgE anti-GAT responses, while markedly augmenting IgE anti-TNP responses in the same mice, and IgE anti-GAT responses in BALB/c mice. However, the presence of functional GAT-specific IgE B cells in nonresponder strains was established by demonstrating IgE anti-GAT responses to GAT complexed with methylated serum albumin in these mice. The implications of these data with respect to H-2 linked Ir gene function and class-specific regulation of antibody responses are discussed.
Footnotes
This work was supported by Grant AI-14732 from the National Institutes of Health and by Grant PCM 75-22422 from the National Science Foundation.